Skip to content

Effect of Multi-component Intervention for Blood Pressure control in Pregnancy: A pilot study

Effect of Multi-component Intervention for Blood Pressure control in Pregnancy: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202306896247858
Enrollment
60
Registered
2023-06-20
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hypertension in Pregnancy

Interventions

Sponsors

Stroke and Cardiovascular Research Training programme
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All consenting pregnant women aged 18-49 years who have chronic hypertension (sustained systolic blood pressure of >/= 140/90 mmHg, present at booking or before 20 weeks gestation, or receiving anti-hypertensives before pregnancy)

Exclusion criteria

Exclusion criteria: - Pregnancy-induced hypertension - Preeclampsia/ eclampsia - Diabetes mellitus - Thyroid disorders - SLE - Hyperlipidemia - Chronic kidney disease - Chronic liver disease - Sickle cell disease

Design outcomes

Primary

MeasureTime frame
•Participant recruitment rates •Participant retention rates •Fidelity to the protocol •Acceptability

Secondary

MeasureTime frame
• Mean change in systolic BP from enrollment to 6 weeks post delivery • The proportion of participants who achieve BP control (<140/90 mm Hg);• The rate of Adverse maternal outcomes (defined as pre-eclampsia, eclampsia, cesarean section, and mortality) • The rate of adverse perinatal outcome (defined as IUGR, IUFD, preterm delivery, NICU admission, perinatal deaths)

Countries

Ghana, Nigeria

Contacts

Public ContactTaiwo Adeola Adedokun

Consultant Cardiologist

adeolaadedokun@gmail.com+2348033914425

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026